Workshop 2
Adaptive immunity

Programme

• 15:45 – 16:00 12 Min. 3 Min.

  • Abstract talk
  • O 007

  A novel antibody targeting the mouse cytomegalovirus gM/gN has potent antiviral activity in vitro and in vivo

  • Larissa Bauer (91054 / DE)

   Adaptive immunity
• 16:00 – 16:15 12 Min. 3 Min.

  • Abstract talk
  • O 008

  Broad and potent NTD and RBD antibodies for SARS-CoV-2 combination therapy

  • Finn Teipel (Cologne / DE)

   Adaptive immunity
• 16:15 – 16:30 12 Min. 3 Min.

  • Abstract talk
  • O 009

  TCR-mediated phenotype heterogeneity of virus-specific CD8+ T cells in chronic viral infections revealed at the single cell level

  • Dr. Sebastian Klein (Hannover / DE)

   Adaptive immunity
• 16:30 – 16:45 12 Min. 3 Min.

  • Abstract talk
  • O 010

  Dendritic cell – T cell interaction in Ebola Virus Infections

  • Linda Niemetz (Hamburg / DE)

   Adaptive immunity
• 16:45 – 17:00 12 Min. 3 Min.

  • Abstract talk
  • O 011

  The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T-cell recognition by targeting CIITA

  • Professor Mirko Trilling (Essen / DE)

   Adaptive immunity
• 17:00 – 17:15 12 Min. 3 Min.

  • Abstract talk
  • O 012

  Induction of local human papilloma virus-specific T cell responses upon intravaginal immunization

  • Lydia Riepler (Innsbruck / AT)

   Adaptive immunity